ZIB

Hits per page

hits 1 - 2 | 2 hits

Sorting

Electronic Resource

Intensive Insulin Therapy and Bone Mineral Density in Type 1 Diabetes Mellitus: A Prospective Study (2000)

Campos Pastor, M. M. ; López-Ibarra, P. J. ; Escobar-Jiménez, F. ; [et al.]

Springer

Osteoporosis international 11 (2000), S. 455-459

add to mindlist on the mindlist

Details

ISSN: 1433-2965

Keywords: Key words:Bone mineral density – Evolution time – Metabolic control – Retinopathy – Type 1 diabetes mellitus

Source: Springer Online Journal Archives 1860-2000

Topics: Medicine

Notes: Abstract: To determine the effect of metabolic control on bone mineral density (BMD) in type 1 diabetes mellitus (type 1 DM), we studied BMD (by dual-energy X-ray energy absorptiometry) and bone remodeling parameters in 62 patients with type 1 DM both before and 7 years after commencement of intensive insulin therapy. Overall outcomes after the 7-year treatment included the stabilization of BMD at all sites, as well as a significant decrease in tartrate-resistant acid phosphatase (TRAP) (4.302 ± 2.62 vs 2.65 ± 0.97 IU/l; p = 0.0001) and increase in intact parathyroid hormone (PTHi) (28.05 ± 15.7 vs 39.78 ± 22.41 ng/l; p = 0.005). Presence of diabetic retinopathy (RTP) versus its absence (non-RTP) was associated with lower BMD in femoral neck (FN) (0.831 ± 0.142 vs 0.756 ± 0.153 mg/cm2; p = 0.03) and Ward’s triangle (WT) (0.736 ± 0.165 vs 0.632 ± 0.172 mg/cm2; p = 0.03), and with a lower T-score in FN (–0.93 ± 1.34 vs –1.70 ± 1.46; p = 0.04) and WT (–0.72 ± 1.42 vs –1.540 ± 1.55; p = 0.04) and Z-score in FN (–0.591 ± 1.23 vs –1.132 ± 1.46; p = 0.01). The percentage of patients with osteopenia or osteoporosis in the RTP group was significantly higher than in the non-RTP group (72% vs 53%, p = 0.05; RR= 3.2) and the glycosylated hemoglobin (HbA1c) levels of the RTP group were also higher (8.53 ± 1.6% vs 7.1 ± 1.1%; p = 0.05). The improvement in metabolic control, increase in body mass index and decrease in resorption parameters could contribute to the stabilization of bone mass in type 1 DM but the presence of retinopathy is a critical factor in the progression of diabetic osteopenia.

Type of Medium: Electronic Resource

URL: http://dx.doi.org/10.1007/s001980070114

Permalink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Paper (German National Licenses)

Fulltext

Electronic Resource

Influence of the catalyst on the kinetics of a RIM formulation (1989)

Rego, J. M. ; Pastor, M. A. ; Campo, J. J. ; [et al.]

New York, NY [u.a.] : Wiley-Blackwell

Journal of Applied Polymer Science 38 (1989), S. 237-248

add to mindlist on the mindlist

Details

ISSN: 0021-8995

Keywords: Chemistry ; Polymer and Materials Science

Source: Wiley InterScience Backfile Collection 1832-2000

Topics: Chemistry and Pharmacology , Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics , Physics

Notes: The influence of three different catalysts [triethylendiamine (TD), stannous octoate (SO), and dibutylindilaurate (DBTDL)] and their blends (TD + SO and TD + DBTDL) on the kinetics of a RIM formulation, based on a high functionality polyether-polyol and a polymeric MDI, has been studied using the adiabatic temperature rise method and Fourier transform infrared spectroscopy. The synergism observed in the DBTDL/TD systems is explained by means of complex formation between the amine-based and metal-based catalysts. Infrared spectroscopy data support this complex formation. The SO/TD systems do not exhibit synergetic behaviour, being the reaction rate controlled by the metal catalyst which complexes the isocyanate group.

Additional Material: 9 Ill.